Epithelioid angiosarcoma of the pericardium: Case report of the challenges in the management of a rare malignancy with poor prognosis

Author:

Guleria Bhupesh1ORCID,Guleria Prerna2ORCID,Husain Azhar3,Jain Anurag3,Raphael Jes1,Sengupta Prasanta2

Affiliation:

1. Department of Medical Oncology, Malignant Diseases Treatment Centre, Pune, Maharashtra, India

2. Department of Pathology, Command Hospital (Southern Command), Pune, Maharashtra, India

3. Department of Nuclear Medicine, Command Hospital (Southern Command), Pune, Maharashtra, India

Abstract

Abstract A primary epithelioid angiosarcoma of the pericardium is a rare soft tissue malignancy. This report describes a young adult woman who presented with progressive dyspnea and pericardial effusion. She was found to have pericardial mass on imaging along with extensive myocardial infiltration. The biopsy of the mass revealed epithelioid angiosarcoma, which was CD34 and CD31-immuno-positive. Due to unresectable disease, she was given a trial of immunotherapy followed by conventional chemotherapy. She showed partial response on interim assessment, but progressed soon after the completion of six cycles and succumbed to her rapidly progressive illness within nine months of diagnosis. This report discusses the diagnostic and therapeutic challenges faced while managing this disease of aggressive tumor biology.

Publisher

Medknow

Reference13 articles.

1. Primary cardiac epithelioid angiosarcoma in a Latin American patient:Case report and literature review;Morgenstern-Kaplan;Case Rep Oncol Med,2019

2. Primary Angiosarcoma of the Pericardium. Case Report and Review of the Literature;Timóteo;Kardiol Pol,2010

3. Extracutaneous angiosarcomas metastatic to the lungs:Clinical and Pathologic Features of Twenty-One Cases;Bocklage;Mod Pathol,2001

4. Primary cardiac sarcoma:25-year cleveland clinic experience;Randhawa;Am J Clin Oncol,2016

5. Angiosarcoma:A review of diagnosis and current treatment;Cao;Am J Cancer Res,2019

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Paclitaxel/pembrolizumab;Reactions Weekly;2024-06-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3